Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 23312551)

1.

Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials?

Furukawa TA, Leucht S.

Schizophr Res. 2013 Mar;144(1-3):105-8. doi: 10.1016/j.schres.2012.12.006. Epub 2013 Jan 9.

PMID:
23312551
2.

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2012 Jun;73(6):856-64. doi: 10.4088/JCP.11r07539. Epub 2012 May 15. Review.

PMID:
22687813
3.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Woods SW, Gueorguieva RV, Baker CB, Makuch RW.

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. Review.

PMID:
16143728
4.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
5.

Placebo or active control trials of antipsychotic drugs?

Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J.

Arch Gen Psychiatry. 2003 May;60(5):458-64. Review.

PMID:
12742866
6.

Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.

Suzuki T, Remington G, Arenovich T, Uchida H, Agid O, Graff-Guerrero A, Mamo DC.

Br J Psychiatry. 2011 Oct;199(4):275-80. doi: 10.1192/bjp.bp.110.083907. Review.

7.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2003;(1):CD001359. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD001359.

PMID:
12535408
8.

Clinical relevance of findings in trials of antipsychotics: systematic review.

Lepping P, Sambhi RS, Whittington R, Lane S, Poole R.

Br J Psychiatry. 2011 May;198(5):341-5. doi: 10.1192/bjp.bp.109.075366. Review.

9.

Benzodiazepines for schizophrenia.

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD006391. doi: 10.1002/14651858.CD006391.pub2. Review.

PMID:
23152236
10.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2000;(2):CD001359. Review. Update in: Cochrane Database Syst Rev. 2003;(1):CD001359.

PMID:
10796640
11.

Maintenance treatment with antipsychotic drugs for schizophrenia.

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM.

Cochrane Database Syst Rev. 2012 May 16;5:CD008016. doi: 10.1002/14651858.CD008016.pub2. Review.

PMID:
22592725
12.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

13.

Music therapy for people with schizophrenia and schizophrenia-like disorders.

Mössler K, Chen X, Heldal TO, Gold C.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004025. doi: 10.1002/14651858.CD004025.pub3. Review.

PMID:
22161383
14.

Benzodiazepines for schizophrenia.

Volz A, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006391. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD006391.

PMID:
17253592
15.

Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

Tollefson GD, Andersen SW.

J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. Review.

PMID:
10192404
16.

Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.

Ardizzone I, Nardecchia F, Marconi A, Carratelli TI, Ferrara M.

Psychopharmacol Bull. 2010;43(2):45-66. Review.

PMID:
21052042
17.

Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.

Singh V, Singh SP, Chan K.

Int J Neuropsychopharmacol. 2010 Mar;13(2):257-71. doi: 10.1017/S1461145709990654. Epub 2009 Sep 24. Review.

PMID:
19775502
18.

Paliperidone extended release: a review of its use in the management of schizophrenia.

Chwieduk CM, Keating GM.

Drugs. 2010 Jul 9;70(10):1295-317. doi: 10.2165/11204840-000000000-00000. Review.

PMID:
20568835
19.

Implications of clinical trial design on sample size requirements.

Leon AC.

Schizophr Bull. 2008 Jul;34(4):664-9. doi: 10.1093/schbul/sbn035. Epub 2008 May 9. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk